TACT method for non‐inferiority testing in active controlled trials
- 18 December 2002
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 22 (2) , 227-238
- https://doi.org/10.1002/sim.1316
Abstract
In active controlled trials without a placebo arm, non‐inferiority testing is often considered but has different objectives. For the objective of demonstrating the efficacy of an experimental treatment or retention of a fraction of the control effect by the treatment, there are two types of statistical methods for testing – the synthesis method and the confidence interval method. According to the study of Wang, Hung and Tsong, the former is efficient under the so‐called constancy condition but may have the alpha error rate inflate rapidly if the condition does not hold. In contrast, the latter method with careful selection of the non‐inferiority margin tends to be conservative if the condition holds and may still have a valid alpha error otherwise unless the effect of the active control is less to a large extent in the active controlled trial than in the historical trials. We developed the TACT method, Two‐stage Active Control Testing, as a viable compromise between the two methods. Through the TACT method, the uninterpretable non‐inferiority testing may be avoided prior to the end of the trial. The TACT method carefully constructed can have a valid alpha error rate and the power close to the synthesis method if the constancy condition holds. In addition, the TACT method is more powerful than the confidence interval method for testing for the efficacy of the new treatment relative to the putative placebo and for showing that the new treatment is not inferior to the active control comparator. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Utility and pitfalls of some statistical methods in active controlled clinical trialsControlled Clinical Trials, 2002
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001
- Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placeboAmerican Heart Journal, 2001
- Modification of Sample Size in Group Sequential Clinical TrialsBiometrics, 1999
- Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery DiseaseCirculation, 1997
- Trials to assess equivalence: the importance of rigorous methodsBMJ, 1996
- Problems in interpreting active control equivalence trialsAccountability in Research, 1996
- Low-molecular-weight heparin during instability in coronary artery diseaseThe Lancet, 1996